Avid Bioservices Inc (CDMO)

[edcpf]

We can be pretty sure placebo events won't be delayed. The schedule depends solely on enrollment which I think we all hope is good. And since look-in is triggered based on events from both arms, nobody knows initially where these events come from. So when they peek in, they see that out of all evented, only e.g. 30% were assigned to the bavituximab arm, and 70% to the placebo one. This example would be good news.